Search

Your search keyword '"Thomas Erker"' showing total 41 results

Search Constraints

Start Over You searched for: Author "Thomas Erker" Remove constraint Author: "Thomas Erker" Topic biology Remove constraint Topic: biology
41 results on '"Thomas Erker"'

Search Results

1. A Novel Na + -K + -Cl − Cotransporter 1 Inhibitor STS66* Reduces Brain Damage in Mice After Ischemic Stroke

2. The search for NKCC1-selective drugs for the treatment of epilepsy: Structure–function relationship of bumetanide and various bumetanide derivatives in inhibiting the human cation-chloride cotransporter NKCC1A

3. Hydrogen sulphide induces HIF-1α and Nrf2 in THP-1 macrophages

4. Resveratrol post-transcriptionally regulates pro-inflammatory gene expression via regulation of KSRP RNA binding activity

5. Synthesis, biological evaluation and 3D-QSAR studies of new chalcone derivatives as inhibitors of human P-glycoprotein

6. Tariquidar and Elacridar Are Dose-Dependently Transported by P-Glycoprotein and Bcrp at the Blood-Brain Barrier: A Small-Animal Positron Emission Tomography and In Vitro Study

7. Multiple blood-brain barrier transport mechanisms limit bumetanide accumulation, and therapeutic potential, in the mammalian brain

8. Selective anticancer activity of the novel thiobenzanilide 63T against human lung adenocarcinoma cells

9. The exploration of thienothiazines as selective butyrylcholinesterase inhibitors

10. The antiepileptic drug mephobarbital is not transported by P-glycoprotein or multidrug resistance protein 1 at the blood–brain barrier: A positron emission tomography study

11. A comparative small-animal PET evaluation of [C-11]tariquidar, [C-11]elacridar and (R)-[C-11]verapamil for detection of P-glycoprotein-expressing murine breast cancer

12. PET and SPECT Radiotracers to Assess Function and Expression of ABC Transporters In Vivo

13. Radiosynthesis and in vivo evaluation of 1-[18F]fluoroelacridar as a positron emission tomography tracer for P-glycoprotein and breast cancer resistance protein

14. Interaction of diltiazem with an intracellularly accessible binding site on CaV1.2

15. Resveratrol blocks Akt activation in angiotensin II- or EGF-stimulated vascular smooth muscle cells in a redox-independent manner

16. Synthesis and in vivo evaluation of the putative breast cancer resistance protein inhibitor [11C]methyl 4-((4-(2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl)phenyl)amino-carbonyl)-2-(quinoline-2-carbonylamino)benzoate

17. Synthesis and Small-Animal Positron Emission Tomography Evaluation of [11C]-Elacridar As a Radiotracer to Assess the Distribution of P-Glycoprotein at the Blood−Brain Barrier

18. Antitumor effects of KITC, a new resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cells

19. ‘Bridged’ stilbene derivatives as selective cyclooxygenase-1 inhibitors

20. Synergistic action of resveratrol, an ingredient of wine, with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells

21. Studies on the chemistry of thienoannelated O,N ‐ and S,N ‐containing heterocycles. 25. Synthesis of new imidazolyl and pyrazolyl derivatives of thiophene as inhibitors of nitric oxide synthase

22. Drug Trapping in hERG Channels does not Require Closure of the Activation Gate

23. A Novel Genistein Prodrug: Design, Synthesis and Bioactivity on Mouse RAW264.7 Macrophages

24. Novel Promising Estrogenic Receptor Modulators: Cytotoxic and Estrogenic Activity of Benzanilides and Dithiobenzanilides

25. Interaction of HM30181 with P-glycoprotein at the murine blood-brain barrier assessed with positron emission tomography

26. A novel PET protocol for visualization of breast cancer resistance protein function at the blood–brain barrier

27. Identification and characterization of diarylimidazoles as hybrid inhibitors of butyrylcholinesterase and amyloid beta fibril formation

28. The third-generation P-glycoprotein inhibitor tariquidar may overcome bacterial multidrug resistance by increasing intracellular drug concentration

29. Synthesis and in vivo evaluation of [11C]tariquidar, a positron emission tomography radiotracer based on a third-generation P-glycoprotein inhibitor

30. Stilbene analogues affect cell cycle progression and apoptosis independently of each other in an MCF-7 array of clones with distinct genetic and chemoresistant backgrounds

31. N-hydroxy-N'-(3,4,5-trimethoxyphenyl)-3,4,5-trimethoxy-benzamidine, a novel resveratrol analog, inhibits ribonucleotide reductase in HL-60 human promyelocytic leukemia cells: Synergistic antitumor activity with arabinofuranosylcytosine

32. No evidence for modulation of endothelial nitric oxide synthase by the olive oil polyphenol hydroxytyrosol in human endothelial cells

33. Cyclooxygenase-1 and Cyclooxygenase-2 Inhibition of Novel 1,2-Disubstituted Imidazoles

34. Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship

35. Studies on the Chemistry of Thienoanellated O,N‐ and S,N‐Containing Heterocycles. Part 25. Synthesis of New Imidazolyl and Pyrazolyl Derivatives of Thiophene as Inhibitors of Nitric Oxide Synthase

36. Synthesis and multidrug-resistance modulating activity of a series of thienothiazines

37. Interaction of Diltiazem with an Intracellularly Accessible Binding Site on CaV1.2

38. Small-animal PET evaluation of [11C]MC113 as a PET tracer for P-glycoprotein

39. Assessing cerebral P-glycoprotein expression and function with PET by combined [11C]inhibitor [11C]substrate scans

40. Novel resveratrol analogs induce apoptosis and cause cell cycle arrest in HT29 human colon cancer cells: Inhibition of ribonucleotide reductase activity

41. Using Structural and Mechanistic Information to Design Novel Inhibitors/Substrates of P-Glycoprotein

Catalog

Books, media, physical & digital resources